Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Apr 2026 for Alamar Biosciences, Inc., €3.4M.
Filing timeline
BuySaleIllumina Innovation Fund II GP, L.L.C.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +3.0%Entry US$23.23 · Close at T+90 US$23.92
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Illumina Innovation Fund II GP, L.L.C.: trading record in brief
Illumina Innovation Fund II GP, L.L.C. discloses dealings in Alamar Biosciences, Inc. to SEC (Form 4). We count 7 filings, every one of them for a trade on 20 April 2026.
Purchases make up the whole of the open-market record (1 purchase, €3.4M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Most recently, on 20 April 2026, the filings show an open-market purchase worth €3.4M in Alamar Biosciences, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Illumina Innovation Fund II GP, L.L.C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
235,294 shares@ US$17.00100.0% of flowCommon StockSEC:0001193125-26-164634:6
Canonical exit: 19 Jul 2026 (T+90)
4,588,364 sharesClass B Common StockSEC:0001193125-26-164634:0
922,152 sharesClass B Common StockSEC:0001193125-26-164634:1
5,510,516 sharesClass B Common StockSEC:0001193125-26-164634:2
5,510,516 sharesCommon StockSEC:0001193125-26-164634:3
346,020 sharesCommon StockSEC:0001193125-26-164634:4
271,782 sharesCommon StockSEC:0001193125-26-164634:5
7 of 7 declarations
